DANIELLE PAGE: Open Payments
NPI 1497429302 · FREMONT, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,879 in 68 payments from 17 companies in 2025. Trend: 2023 $2,144 · 2024 $1,782 · 2025 $1,879
Food & beverage: $1,814Education: $66
| Company | Payments | Amount |
|---|---|---|
| Genentech USA, Inc. | 6 | $337 |
| Regeneron Healthcare Solutions, Inc. | 12 | $321 |
| GlaxoSmithKline, LLC. | 11 | $241 |
| GENZYME CORPORATION | 7 | $229 |
| ARS Pharmaceuticals Operations, Inc. | 6 | $148 |
| LEO Pharma Inc. | 4 | $98 |
| Novartis Pharmaceuticals Corporation | 4 | $96 |
| Amgen Inc. | 3 | $68 |
| Optinose US, Inc. | 3 | $59 |
| Grifols USA, LLC | 2 | $56 |
Products named: DUPIXENT, Xolair, NUCALA, NEFFY, ADBRY, TEZSPIRE, Xhance, Xembify.
Industry payments across CA — which companies pay providers there.
